RILEY LARNER: Open Payments
NPI 1194485904 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,881 in 82 payments from 16 companies in 2025. Trend: 2023 $125 · 2024 $572 · 2025 $1,881
Food & beverage: $1,797Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $397 |
| Madrigal Pharmaceuticals | 12 | $350 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $298 |
| Janssen Biotech, Inc. | 12 | $297 |
| PFIZER INC. | 6 | $128 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $89 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| Novo Nordisk Inc | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
Products named: REZDIFFRA, TREMFYA, ENTYVIO, RINVOQ, SKYRIZI, VELSIPITY, XIFAXAN, ZENPEP.
Industry payments across MI — which companies pay providers there.
